Atorvastatin Calcium
Product Images NDC 63304-827

8 FDA label images from Sun Pharmaceutical Industries Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 63304-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of atorvastatin calcium, showing its molecular arrangement including aromatic rings, hydroxyl groups, fluorine, and calcium ions as part of the compound's structure.*
FDA Label Image

Figure1 (Image 02)

Figure1 (Image 02)
A line graph compares cumulative incidence percentages over approximately 3.5 years for Atorvastatin and placebo groups. The solid line represents Atorvastatin, and the dashed line represents placebo, showing lower cumulative incidence for Atorvastatin. The x-axis is labeled in years, and the y-axis shows cumulative incidence percentage.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A cumulative hazard plot graph depicting the time to first primary endpoint over four years of follow-up, comparing Atorvastatin and placebo groups. The vertical axis shows cumulative hazard percentage, and the horizontal axis shows time in years. The graph includes a hazard ratio (HR) of 0.63 with confidence interval and p-value.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
A line graph depicting the percentage of subjects experiencing a major cardiovascular event over time (in years) for Atorvastatin 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint up to 5 years, and the y-axis shows the percentage of subjects experiencing the event up to 0.2. The graph includes a hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Spl-atorva-label1 (Spl Atorva Label1)

Spl-atorva-label1 (Spl Atorva Label1)
Atorvastatin Calcium Tablets, USP 10 mg packaging label from Sun Pharmaceutical Industries Inc. The label indicates the container holds 90 tablets, for prescription use only. The label includes NDC 63304-827-90, manufacturer information, and usage storage instructions, with a printed barcode.*
FDA Label Image

Spl-atorva-label2 (Spl Atorva Label2)

Spl-atorva-label2 (Spl Atorva Label2)
Atorvastatin Calcium Tablets, USP 20 mg by Sun Pharmaceutical Industries Inc. The label shows a pack containing 90 tablets. The packaging includes the NDC number 63304-828-90 and states the product is Rx only. It features both vertical and horizontal barcodes and a note about non-varnish area.*
FDA Label Image

Spl-atorva-label3 (Spl Atorva Label3)

Spl-atorva-label3 (Spl Atorva Label3)
Label for Atorvastatin Calcium Tablets USP 40 mg by Sun Pharmaceutical Industries Inc. The label shows NDC 63304-829-90 and indicates a package containing 90 film-coated tablets. The label includes storage instructions and manufacturing information with a non-varnish area marked on the right side.*
FDA Label Image

Spl-atorva-label4 (Spl Atorva Label4)

Spl-atorva-label4 (Spl Atorva Label4)
Label for Atorvastatin Calcium Tablets, USP 80 mg by Sun Pharmaceutical Industries Inc. The label indicates 90 tablets per package with prescription-only status. It includes directions for use, packaging instructions, and a barcode, along with the note 'NON VARNISH AREA' on one side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.